[Objective evaluation of cataract development under treatment with cytochrome C, sodium succinate, adenosine, nicotinamide and sorbitol].
D000241:Adenosine / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D002386:Cataract / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003574:Cytochrome c Group / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D011897:Random Allocation; D013012:Sorbitol / Q000627:therapeutic use*; D013386:Succinates / Q000627:therapeutic use*; D019802:Succinic Acid
D003574:Cytochrome c Group; D013386:Succinates; D009536:Niacinamide; D013012:Sorbitol; D019802:Succinic Acid; D000241:Adenosine
Objektivierte Kataraktentwicklung unter Therapie mit Cytochrom C, Natriumsuccinat, Adenosin, Nicotinsäureamid und Sorbit.